Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

These harbingers reflect the deep and rapid changes in the global health sector that are upending business models and forcing all stakeholders to re-evaluate their approaches to bringing healthcare to ...

The company's intangible assets--its proprietary data sets, technology, expertise, and reputation--place Quintiles IMS well ahead of its closest competitors. IMS Health's legacy business compiles ...

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health today announced the acquisition of Semantelli Corporation, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer ...

Health IT vendor IMS Health and biopharmaceutical research firm Quintiles Transnational Holdings have agreed to merge. Per the agreement, the companies will be combined in an all-stock merger of ...

IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...

NEW YORK, April 18 (Reuters) - IMS Health , which provides market data on pharmaceuticals sales, on Wednesday reported first-quarter profit fell 27 percent from a year ago, when it had tax benefits, ...

CHICAGO (MarketWatch) -- IMS Health on Wednesday reported first-quarter net income of $118.1 million, or 56 cents a share, compared with last year's $30.3 million, or 13 cents a share. The figure in ...

Companies using technology to try to shake up the health-care industry have been rewarded with sky-high valuations. IMS Health Holdings won't be one. IMS, a 60-year-old Danbury company that sells data ...